Studies have shown that overexpression of Adra2a inhibits insulin secretion of pancreatic β cells, affects energy and fat metabolism, and plays an important regulatory role in the occurrence of T2D [17, 18]. Here, ADRA2A is linked to type 2 diabetes mellitus.